scholarly journals Systemic lupus erythematosus presenting as stevens johnson syndrome in a thirty years old female: a case report

2019 ◽  
Vol 6 (1) ◽  
pp. 20-21
Author(s):  
Mohammad Shariq Mukarram

Background: SJS occurs almost exclusively secondary to drugs but very rarely, SLE can be an inciting factor for SJS without presence of an offending drug. The association is extremely rare, however few cases have been reported. Case presentation: We present a case report of a thirty year old female who presented to the rheumatology clinic with complaints of rash on her face, swelling of the lips and oral ulcers with severe hemorrhagic cheilitis. She also complained of persistent high grade fever with development of blisters on her face and oropharyngeal mucosa. She had been suffering from pain in multiple joints which did not respond to NSAIDs. A diagnosis of SLE presenting as SJS was established. Patient was given good supportive care, steroids, DMARDs and analgesics, to which she responded well and recovered. Conclusion: Stevens Johnson Syndrome is an uncommon, severe dermatological condition usually caused secondary to drugs. Secondary cause of the disease may rarely be co-existence of an autoimmune condition like SLE, as present in our patient.

2019 ◽  
Vol 1 (2) ◽  
pp. 23-26
Author(s):  
Ghada ElGohary ◽  
Ghada ElGohary ◽  
Mohammad Al Nahedh ◽  
Riad ElFakih

Lenalidomide is a second generation immunomodulatory agent and a potent analogue of thalidomide that is FDA approved mainly for the treatment of multiple myeloma (MM) and transfusion-dependent anemia due to low or intermediate-1- risk myelodysplastic syndromes (MDS) associated with 5q deletion among other indications. Through its action on the immune system, lenalidomide alters the production of different cytokines ultimately resulting in immune activation against tumors. This immune activation may lead to collateral immune toxicities like fever, angioedema, Stevens-Johnson syndrome, tumor flare and others. Here we report a case of lenalidomide-induced high grade fever in a patient with MM and we summarize the literature about the physiology of such reaction and how to mitigate this adverse event.


Author(s):  
Isabelle Zare ◽  
Olasunkanmi W. Adeyinka ◽  
Jude K. A. des Bordes

2021 ◽  
Vol 9 (7) ◽  
Author(s):  
Preeti Shakya ◽  
Amit Sharma Nepal

2020 ◽  
Vol 17 (3) ◽  
pp. 169-173
Author(s):  
Takahiro Goto ◽  
Atsushi Yamashiro ◽  
Nobuyuki Maruyama ◽  
Fusahiro Hirano ◽  
Toshiyuki Nakasone ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document